Tag: Entrectinib

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Entrectinib

Targeted Drug ROS1 Inhibitors for NSCLC Market Emerging Trend and Forecast to 2028 | Roche ...

Added to Collection on: 2021-08-16 02:03:45

Tags for this article:

Chemical compounds
Organic compounds
Orphan drugs
Tyrosine kinase receptors
ROS1
Lung cancer
Chloroarenes
Breakthrough therapy
Crizotinib
Non-small-cell lung carcinoma
Entrectinib
Lorlatinib

Click the tags to see associated articles and topics

View Article Details
Targeted Drug ROS1 Inhibitors For NSCLC Market Size, Trends, and Key Players

Added to Collection on: 2021-09-04 13:59:51

Tags for this article:

Chemical compounds
Organic compounds
Lung cancer
Orphan drugs
Tyrosine kinase receptors
ROS1
Chloroarenes
Non-small-cell lung carcinoma
Entrectinib
Crizotinib
Lorlatinib
ALK inhibitor

Click the tags to see associated articles and topics

View Article Details
Turning Point Therapeutics Presents Early Clinical Data for Repotrectinib From Care Study ...

Added to Collection on: 2021-10-23 13:44:14

Tags for this article:

Tyrosine kinase receptors
Organ systems
Cancer
Branches of biology
ROS1
ALK inhibitor
Anaplastic lymphoma kinase
Inflammatory myofibroblastic tumour
Neuroblastoma
Radiation therapy
Entrectinib
Crizotinib
Turning Point Therapeutics, Inc.

Click the tags to see associated articles and topics

View Article Details
EP. 1: Targeting the TRK Pathway in Pediatric or Adult Patients with Advanced or Surgically ...

Added to Collection on: 2021-12-23 20:26:30

Tags for this article:

Tyrosine kinase receptors
Chemical compounds
Branches of biology
Orphan drugs
Drugs
Breakthrough therapy
Benzamides
Entrectinib
ROS1
Larotrectinib
Anaplastic lymphoma kinase
Tropomyosin receptor kinase C

Click the tags to see associated articles and topics

View Article Details
Early durability data lifts Turning Point, but market size questions loom | Evaluate

Added to Collection on: 2022-04-14 14:21:42

Tags for this article:

Chemical compounds
Organic compounds
Tyrosine kinase receptors
Health sciences
Orphan drugs
Breakthrough therapy
ROS1
Tyrosine kinase inhibitors
Lung cancer
Entrectinib
Non-small-cell lung carcinoma
Roche

Click the tags to see associated articles and topics

View Article Details
BMS bets $4.1B on lung cancer drug that could best products from Pfizer, Roche

Added to Collection on: 2022-06-03 19:24:01

Tags for this article:

Chemical compounds
Organic compounds
Aromatic compounds
Tyrosine kinase receptors
Breakthrough therapy
ROS1
Lung cancer
Orphan drugs
Entrectinib
Anaplastic lymphoma kinase
Non-small-cell lung carcinoma
Crizotinib

Click the tags to see associated articles and topics

View Article Details
FDA Approves Foundation Medicine Test as CDx With Roche's Rozlytrek | Genomeweb

Added to Collection on: 2022-06-09 14:23:36

Tags for this article:

Chemical compounds
Organic compounds
Drugs
Orphan drugs
Breakthrough therapy
Tyrosine kinase receptors
Entrectinib
Piperazines
ROS1
Roche
Non-small-cell lung carcinoma
Anaplastic lymphoma kinase
Foundation Medicine

Click the tags to see associated articles and topics

View Article Details
Nerviano Medical Sciences S.r.l. Announces Collaboration and Option to License ...

Added to Collection on: 2022-09-21 11:22:08

Tags for this article:

Branches of biology
Chemical compounds
Biology
Lactams
Benzamides
PARP inhibitor
PARP1
Entrectinib
Treatment of cancer
Poly (ADP-ribose) polymerase
ROS1
Temozolomide
Nerviano Medical Sciences S.r.l.
Italy

Click the tags to see associated articles and topics

View Article Details
Week in Review: Mitigating testing bottlenecks | new CRISPR enzyme | FDA liquid biopsy approval

Added to Collection on: 2023-01-06 09:01:29

Tags for this article:

Chemical compounds
Biotechnology
Branches of biology
Biology
Medical genetics
Molecular diagnostics
Foundation Medicine
ROS1
Entrectinib
Medical laboratory

Click the tags to see associated articles and topics

View Article Details
Dosing webpage lands Roche in U.K. pharma marketing watchdog's crosshairs

Added to Collection on: 2023-09-21 20:10:19

Tags for this article:

Pfizer
Research and development in the United States
Tyrosine kinase receptors
Roche
Entrectinib
Albert Bourla
ROS1
Pharma
United Kingdom

Click the tags to see associated articles and topics

View Article Details